Authors: Meyers, PA Krailo, MD Ladanyi, M Chan, KW Sailer, SL Dickman, PS Baker, DL Davis, JH Gerbing, RB Grovas, A Herzog, CE Lindsley, KL Liu-Mares, W Nachman, JB Sieger, L Wadman, J Gorlick, RG

Citation: Pa. Meyers et al., High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis, J CL ONCOL, 19(11), 2001, pp. 2812-2820

Authors: Cormier, JN Patel, SR Herzog, CE Ballo, MT Burgess, MA Feig, BW Hunt, KK Raney, RB Zagars, GK Benjamin, RS Pisters, PWT

Citation: Jn. Cormier et al., Concurrent ifosfamide-based chemotherapy and irradiation - Analysis of treatment-related toxicity in 43 patients with sarcoma, CANCER, 92(6), 2001, pp. 1550-1555

Authors: Herzog, CE Zwelling, LA

Citation: Ce. Herzog et La. Zwelling, Drug-induced cytotoxicity in tissue culture, METH MOL B, 95, 2000, pp. 205-213

Authors: Brewer, M Gershenson, DM Herzog, CE Mitchell, MF Silva, EG Wharton, JT

Citation: M. Brewer et al., Outcome and reproductive function after chemotherapy for ovarian dysgerminoma, J CL ONCOL, 17(9), 1999, pp. 2670-2675

Authors: Worth, LL Slopis, JM Herzog, CE

Citation: Ll. Worth et al., Congenital hepatoblastoma and schizencephaly in an infant with Beckwith-Wiedemann syndrome, MED PED ONC, 33(6), 1999, pp. 591-593

Authors: Herzog, CE Holmes, KA Tuschong, LM Ganapathi, R Zwelling, LA

Citation: Ce. Herzog et al., Absence of topoisomerase II beta in an amsacrine-resistant human leukemia cell line with mutant topoisomerase II alpha, CANCER RES, 58(23), 1998, pp. 5298-5300